HLS Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-10.29	-12.43	-19.66	-27.53	-23.6	-13.12
Depreciation & Amortization	21.99	21.82	22.72	31.94	34.4	30.26
Stock-Based Compensation	1.4	1.91	1.62	-0.54	2.92	2.35
Other Adjustments	0.75	1.1	2.18	6.88	1.67	-0.05
Change in Receivables	-0.37	-	-	-	-	-
Changes in Inventories	0.65	-	-	-	-	-
Changes in Accounts Payable	-0.08	-	-	-	-	-
Changes in Income Taxes Payable	0.07	-	-	-	-	-
Changes in Other Operating Activities	10	4.73	1.14	5.04	1.55	-3.02
Operating Cash Flow	19.95	17.13	8	15.79	16.94	16.43
Operating Cash Flow Growth	85.31%	114.05%	-49.31%	-6.81%	3.12%	75.82%
Capital Expenditures	-0.18	-0.21	-0.02	-0.04	-0.05	-0.05
Purchases of Intangible Assets	-1.88	-1.5	-	-0.15	-0.1	-0.64
Payments for Business Acquisitions	-	-	-1.5	-	-10	-3.82
Proceeds from Business Divestments	-	-	13.25	-	-	-
Investing Cash Flow	-2.07	-1.7	11.74	-0.19	-10.15	-4.51
Long-Term Debt Issued	57.24	57.24	-	-	10	-
Long-Term Debt Repaid	49.97	74.99	21.04	8.86	9.78	10.5
Net Long-Term Debt Issued (Repaid)	107.21	132.23	21.04	8.86	19.78	10.5
Issuance of Common Stock	-	-	-	0.13	0.18	4.91
Repurchase of Common Stock	1.62	1.8	0.6	1.55	1	0.05
Net Common Stock Issued (Repurchased)	1.62	1.8	0.6	1.69	1.18	4.96
Common Dividends Paid	-	-	-	-2.4	-4.96	-5.12
Other Financing Activities	-2.02	-2	-1.72	-1.97	-1.3	-0.64
Financing Cash Flow	-23.54	-21.56	-23.36	-14.64	-6.86	-11.4
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.24	0.4	-0.87	0.27	-0.39	0.05
Net Cash Flow	-6.23	-5.73	-4.5	0.96	-0.06	0.52
Free Cash Flow	19.77	16.93	7.99	15.75	16.9	16.38
Free Cash Flow Growth	16.81%	111.88%	-49.28%	-6.80%	3.14%	76.00%
FCF Margin	35.47%	30.50%	14.11%	24.97%	27.49%	27.30%
Free Cash Flow Per Share	0.63	0.54	0.25	0.49	0.52	0.51
Levered Free Cash Flow	129.36	146.14	25.23	18.26	32.08	24.58
Unlevered Free Cash Flow	27.35	21.05	17.17	20.53	17.32	20.03

Updated May 15, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.